Follow
Elisabeth Ersvær
Elisabeth Ersvær
INN University - INland Norway University of Applied Sciences
Verified email at inn.no - Homepage
Title
Cited by
Cited by
Year
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
K Kisand, AS Bøe Wolff, KT Podkraj¹ek, L Tserel, M Link, KV Kisand, ...
Journal of Experimental Medicine 207 (2), 299-308, 2010
7332010
Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cells
O Bruserud, C Stapnes, E Ersvaer, BT Gjertsen, A Ryningen
Current pharmaceutical biotechnology 8 (6), 388-400, 2007
1872007
The proteasome inhibitors bortezomib and PR‐171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells
C Stapnes, AP Døskeland, K Hatfield, E Ersvær, A Ryningen, JB Lorens, ...
British journal of haematology 136 (6), 814-828, 2007
1462007
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
L Cassetta, K Bruderek, J Skrzeczynska-Moncznik, O Osiecka, X Hu, ...
Journal for immunotherapy of cancer 8 (2), 2020
1372020
Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells
E Ersvaer, K Liseth, J Skavland, BT Gjertsen, Ø Bruserud
BMC immunology 11, 1-12, 2010
982010
Heat shock protein 90-a potential target in the treatment of human acute myelogenous leukemia
H Reikvam, E Ersvaer, O Bruserud
Current cancer drug targets 9 (6), 761-776, 2009
742009
Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators
K Hatfield, AM Øyan, E Ersvaer, KH Kalland, P Lassalle, BT Gjertsen, ...
British journal of haematology 144 (1), 53-68, 2009
732009
The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity
E Ersvaer, AO Kittang, P Hampson, K Sand, BT Gjertsen, JM Lord, ...
Toxins 2 (1), 174-194, 2010
722010
Interleukin-6 in allogeneic stem cell transplantation: its possible importance for immunoregulation and as a therapeutic target
THA Tvedt, E Ersvaer, AA Tveita, Ø Bruserud
Frontiers in immunology 8, 262167, 2017
652017
Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte-and platelet …
ÇA Akkök, K Liseth, T Hervig, A Ryningen, Ø Bruserud, E Ersvær
Cytotherapy 11 (6), 749-760, 2009
632009
Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2: Bax ratio and …
A Ryningen, E Ersvær, AM Øyan, KH Kalland, OK Vintermyr, BT Gjertsen, ...
Leukemia research 30 (12), 1531-1540, 2006
612006
Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status …
H Reikvam, KJ Hatfield, E Ersvaer, R Hovland, J Skavland, BT Gjertsen, ...
British journal of haematology 156 (4), 468-480, 2012
572012
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
H Fredly, E Ersvær, AO Kittang, G Tsykunova, BT Gjertsen, Ø Bruserud
Clinical epigenetics 5, 1-15, 2013
552013
Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I
ASB Wolff, BEV Oftedal, K Kisand, E Ersvaer, K Lima, ES Husebye
Scandinavian journal of immunology 71 (6), 459-467, 2010
532010
Long‐term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells
K Liseth, E Ersvær, JF Abrahamsen, I Nesthus, A Ryningen, Ø Bruserud
Transfusion 49 (8), 1709-1719, 2009
522009
Myeloid-derived suppressor cells in hematologic diseases: promising biomarkers and treatment targets
N Bizymi, S Bjelica, AO Kittang, S Mojsilovic, M Velegraki, C Pontikoglou, ...
HemaSphere 3 (1), e168, 2019
512019
Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and …
H Reikvam, KJ Hatfield, P Lassalle, A Olsnes Kittang, E Ersvaer, ...
Expert opinion on investigational drugs 19 (2), 169-183, 2010
492010
Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis
H Fredly, E Ersvær, BT Gjertsen, Ø Bruserud
Oncology reports 25 (6), 1549-1556, 2011
472011
Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia‐associated antigen associated with autoantibody …
E Ersvaer, JY Zhang, E McCormack, A Olsnes, N Ånensen, E M. Tan, ...
European Journal of Haematology 79 (3), 210-225, 2007
442007
Effects of interferon gamma on native human acute myelogenous leukaemia cells
E Ersvaer, J Skavland, E Ulvestad, BT Gjertsen, Ø Bruserud
Cancer Immunology, Immunotherapy 56, 13-24, 2007
432007
The system can't perform the operation now. Try again later.
Articles 1–20